| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_85483ac98517c2c3d67bb829aa5d816f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J1-067 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J1-1468
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-13 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61J1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 |
| filingDate |
2017-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a6b8b0c85811c7cfe95b362acbf1d57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57f30de6043a532b15310aa72253c268
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20720bfa9edc3bdf38bbfcb8220e689e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e60a992632299b84ff098531fb443771
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ebce9d86783cddd4db33b15e938abb64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbed2897287e74f4cb16b2e5c5d8ec9f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef682d15d3187a6b6060bdded3d9e478 |
| publicationDate |
2019-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-110267645-A |
| titleOfInvention |
Ophthalmic compositions for the treatment of dry eye |
| abstract |
The present invention provides a pharmaceutical composition for the topical treatment of dry eye comprising about 0.05 to 0.1% (w/v) cyclosporin dissolved in 1-perfluorobutyl-pentane and providing for its administration and treatment methods. The invention also provides kits comprising such compositions. |
| priorityDate |
2016-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |